|Articles|March 15, 2005
Ophthalomology?!-Who needs to learn that?
In the first issue of Ophthalmology Times after assuming the mantle of chief medical editor, I wrote a piece praising this publication as an effective instrument for providing important, clinically relevant information in ophthalmology. I wish the same could be said for America's medical schools.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5











































.png)


